Join the Chronic Migraine group to help and get support from people like you.
Chronic Migraine News (Page 2)
Related terms: Migraine, Chronic
Too Often, ER Docs Don't Spot Migraines in Minority Kids
THURSDAY, Feb. 6, 2025 – Kids and teens can also get migraines, but Black and Hispanic children seen in ERs are more likely to have their condition go undiagnosed, new research shows. That's...
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
WEDNESDAY, Feb. 5, 2025 – The U.S. Food and Drug Administration has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults. The approval was ...
Beta Blocker Propranolol Might Reduce Migraine Stroke Risk
MONDAY, Feb. 3, 2025 – A common drug used to prevent migraines might have an additional benefit – protecting women against stroke. Women taking the beta blocker propranolol to ward off migraines...
Propranolol May Reduce Overall Stroke Risk in Women With Migraine
FRIDAY, Jan. 31, 2025 – Propranolol is associated with a reduced risk for overall stroke among women with migraine, with a more pronounced protective effect for ischemic stroke, according to a study...
Quick Fix? New Migraine Medicine, Qulipta, May Start Working Right Away
THURSDAY, Dec. 26, 2024 – Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent their terrible symptoms. But a recently approved daily...
Atogepant Superior for Efficacy, Functional Measures in Migraine
THURSDAY, Dec. 26, 2024 – For adults with migraine, atogepant 60 mg once daily was superior to placebo for efficacy and functional measures of treatment across three trials, according to research...
Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
TUESDAY, Oct. 29, 2024 – In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Annals of...
Study Addresses Differentiating Meniere Disease, Vestibular Migraine
THURSDAY, Oct. 3, 2024 – The dissociation between pathological caloric testing and a normal video head impulse test can differentiate between Meniere disease (MD) and vestibular migraine (VM),...
Review Compares Drug Interventions for Acute Migraine Treatment
MONDAY, Sept. 23, 2024 – All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for the acute treatment of migraine among adults,...
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine
WEDNESDAY, Sept. 18, 2024 – Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine...
Monoclonal Antibody Tops Placebo for Reducing Migraine Frequency
WEDNESDAY, Sept. 4, 2024 – The humanized monoclonal antibody directed against the pituitary adenylate cyclase-activating polypeptide (PACAP) ligand, Lu AG09222, is better than placebo for reducing...
Migraine Drug Ubrelvy May Stop Headaches Before They Start
THURSDAY, Aug. 29, 2024 – A migraine drug can help stop the devastating headaches in their tracks, allowing sufferers to go about their daily lives with little to no symptoms, a new clinical trial...
Ubrogepant Administered During Prodrome Beneficial for Migraine
WEDNESDAY, Aug. 28, 2024 – For adults experiencing migraine attacks with moderate-to-severe headache pain, ubrogepant administered during prodrome is beneficial for patient-reported outcomes,...
No Link Found Between Migraines, Parkinson's Disease
FRIDAY, Aug. 23, 2024 – Women who suffer frequent migraines don’t have any increased risk of developing Parkinson’s disease, finds a new study that refutes earlier research. “These results are reass...
Migraine in Women Not Linked to Risk for Parkinson Disease
THURSDAY, Aug. 22, 2024 – Migraine is not associated with an increased risk for developing Parkinson disease (PD) among women, according to a study published online Aug. 21 in Neurology. Ricarda S....